Molecular epidemiology of HIV-1 clades in Southern Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 8, 2010, Pages 1044-1049

  Raboni, Sonia Mara ^a   de Almeida, Sérgio Monteiro ^a   Rotta, Indianara ^a   Ribeiro, Cléa Elisa Lopes ^a,b   Rosario, Debra ^c   Vidal, Luine Rosele ^a   Nogueira, Meri Bordignon ^a   Riedel, Maristela ^d   da Graça Winhescki, Maria ^d   Ferreira, Kátia Antunes ^a   Ellis, Ronald ^c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Centro de Epidemiologia   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Secretaria Municipal de Saude   (Brazil)

Author keywords

Genetic variability; HIV; HIV exposure; Subtypes

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650822324     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762010000800015     Document Type: Review

References (28)

1. Ariën KK, Vanham G, Arts EJ 2007. Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 5: 141-151.
2. Bello G, Aulicino PC, Ruchansky D, Guimarães ML, Lopez-Galindez C, Casado C, Chiparelli H, Rocco C, Mangano A, Sen L, Morgado MG 2010. Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay. Retrovirology 7: 22.
3. Bello G, Eyer-Silva WA, Couto-Fernandez JC, Guimarães ML, Chequer-Fernandez SL, Teixeira SL, Morgado MG 2007. Demographic history of HIV-1 subtypes B and F in Brazil. Infect Genet Evol 7: 263-270.
4. Bello G, Guimarães ML, Morgado MG 2006. Evolutionary history of HIV-1 subtype B and F infections in Brazil. AIDS 20: 763-768.
5. Bello G, Guimarâes ML, Passaes CP, Matos Almeida SE, Veloso VG, Morgado MG 2009. Short communication: evidences of recent decline in the expansion rate of the HIV type 1 subtype C and CRF31_BC epidemics in southern Brazil. AIDS Res Hum Retroviruses 25: 1065-1069.
6. Bello G, Passaes CP, Guimarães ML, Lorete RS, Matos Almeida SE, Medeiros RM, Alencastro PR, Morgado MG 2008. Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 22: 1993-2000.
7. Bongertz V, Bou-Habib DC, Brígido LF, Caseiro M, Chequer PJ, Couto-Fernandez JC, Ferreira PC, Galvão-Castro B, Greco D, Guimarães ML, Linhares de Carvalho MI, Morgado MG, Oliveira CA, Osmanov S, Ramos CA, Rossini M, Sabino E, Tanuri A, Ueda M 2000. HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization. J Acquir Immune Defic Syndr 23: 184-193.
8. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A, Brazilian Network for Drug Resistance Surveillance 2003. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS 17: 1063-1069.
9. Cabral VP, Cunha CB, Magalhaes EFL, Pinto-Neto LF, Couto-Fernandez JC, Dietze R, Morgado MG, Ribeiro-Rodrigues R 2006. Human immunodeficiency virus type-1 subtypes of infected patients in Espírito Santo, Brazil. Mem Inst Oswaldo Cruz 101: 881-885.
10. Dias CF, Nunes CC, Freitas IO, Lamego IS, Oliveira IM, Gilli S, Rodrigues R, Brigido LF 2009. High prevalence and association of HIV-1 non-B subtype with specific sexual transmission risk among antiretroviral naïve patients in Porto Alegre, RS, Brazil. Rev Inst Med Trop Sao Paulo 51: 191-196.
11. Ferreira JLP, Thomaz M, Rodrigues R, Harrad D, Oliveira CM, Oliveira CAF, Batista JPG, Ito TS, Brigido LFM 2008. Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. Mem Inst Oswaldo Cruz 103: 800-808.
12. Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, Pillay D, Dunn D, UK Collaborative Group on HIV Drug Resistance 2009. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis 48: 1296-1305.
13. Kantor R 2006. Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis 19: 594-606.
14. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, Eller LA, Eller M, Makumbi F, Birx D, Wabwire-Mangen F, Serwadda D, Sewankambo NK, Quinn TC, Wawer M, Gray R 2008. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197: 707-713.
15. Kosakovsky Pond SL, Smith DM 2009. Are all subtypes created equal? The effectiveness of antiretroviral therapy against nonsubtype B HIV-1. Clin Infect Dis 48: 1306-1309.
16. Leitner T, Foley B, Hahn BH, Marx P, McCutchan F, Mellors JW, Wolinsky S, Korber B 2003. HIV Sequence Compendium 2003, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, LA-UR 04-7420.
17. Locateli D, Stoco PH, de Queiroz AT, Alcântara LC, Ferreira LG, Zanetti CR, Rodrigues R, Grisard EC, Pinto AR 2007. Molecular epidemiology of HIV-1 in Santa Catarina state confirms increases of subtype C in Southern Brazil. J Med Virol 79: 1455-1463.
18. Meira DA 2002. Acquired immunodeficiency syndrome in Brazil. Croat Med J 43: 475-479.
19. Moore JP, Parren PW, Burton DR 2001. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 75: 5721-5729.
20. MS - Ministério da Saúde, Brasil 2005. Programa Nacional de DST/ AIDS BMoH. Epidemiologic bulletin - AIDS II: 1. Available from: http://www.aids.gov.br/sites/default/files/arquivos_anexos/BOLETIM.pdf. (accessed Aug 31 2010).
21. MS - Ministério da Saúde, Brasil 2008. Programa Nacional de DST/ AIDS BMoH. Epidemiologic bulletin - AIDS V: 1 Available from: http://www.aids.gov.br/sites/default/files/Boletim2008_versao1_6.pdf (accessed Dec 07 2010).
22. MS - Ministério da Saúde, Brasil 2009. Programa Nacional de DST/ AIDS BMoH. Epidemiologic bulletin - AIDS VI: 1. Preliminary version. Available from: http://www.aids.gov.br/data/Pages/LUMIS624DE984PTBRIE.htm. (accessed Nov 25 2009).
23. Perrin L, Kaiser L, Yerly S 2003. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 3: 22-27.
24. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F
25. Lemée V, Damond F, Robertson DL, Simon F 2009. A new human immunodeficiency virus derived from gorillas. Nat Med 15: 871-872.
26. Requejo HI 2006. Worldwide molecular epidemiology of HIV. Rev Saude Publica 40: 331-345.
27. Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, Brigido L, Pires IL, Morgado MG, Dantas MC, Barreira D, Teixeira PR, Cassol S, Tanuri A, Brazilian Network for Drug Resistance Surveillance 2003. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 17: 11-21.
28. Toledo PV, de Carvalho DS, de Rossi SG, Brindeiro R, de Queiroz-Telles F 2010. Genetic diversity of human immunodeficiency virus- 1 isolates in Paraná, Brazil. Braz J Infect Dis 14: 230-236.